The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Beamion PANTUMOR-1: A phase II, multicenter, multicohort, open-label trial to evaluate the efficacy and safety of the oral HER2-selective tyrosine kinase inhibitor zongertinib for the treatment of HER2-mutated or overexpressed/amplified solid tumors.
 
Alison Schram
Consulting or Advisory Role - Blueprint Medicines; Endeavor BioMedicines; Flagship Pioneering; Mersana; Merus NV; PMV Pharma; Redona Therapeutics; Relay Therapeutics; Repare Therapeutics; Schrodinger
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Black Diamond Therapeutics (Inst); Elevation Oncology (Inst); Kura Oncology (Inst); Lilly (Inst); Merus (Inst); Pfizer (Inst); PMV Pharma (Inst); Relay Therapeutics (Inst); Repare Therapeutics (Inst); Revolution Medicines (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - PMV Pharma
 
Timothy Clay
Honoraria - MSD; Roche; Specialised Therapeutics; The Limbic
Consulting or Advisory Role - Astra Zeneca / Daiichi Sankyo; Ipsen; Janssen; Merck/Pfizer; Roche; Takeda
Speakers' Bureau - Roche
Research Funding - Abbvie (Inst); Amgen (Inst); Bayer (Inst); BeiGene (Inst); BMS GmbH & Co. KG (Inst); BridgeBio Pharma (Inst); Clovis Oncology (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Exelixis (Inst); Immutep (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Boehringer Ingelheim; Daiichi Sankyo; Daiichi Sankyo/UCB Japan
(OPTIONAL) Uncompensated Relationships - Merck KGaA
 
Hans Prenen
Honoraria - Amgen; AstraZeneca; Merck
Consulting or Advisory Role - AstraZeneca; Biocartis
 
John Park
No Relationships to Disclose
 
Lukas Lunger
Employment - Boehringer Ingelheim
Honoraria - Janssen
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Merck
Research Funding - Janssen
Travel, Accommodations, Expenses - Merck
 
Joanna Hussain
Employment - Boehringer Ingelheim
 
Daniela Maier
Employment - Boehringer Ingelheim
 
Shigehisa Kitano
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Janssen; Lilly Japan; Merck KGaA; MSD; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Chugai Pharma; GlaxoSmithKline; ImmuniT Research Inc.; Kyowa Kirin; Ono Pharmaceutical; Rakuten Medical; Sumitomo Dainippon Pharma; United Immunity
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kyowa Kirin; Loxo/Lilly (Inst); Merck KGaA; MSD (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Takara Bio (Inst); Takeda (Inst)
 
Ecaterina Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics; Fate Therapeutics; Mersana; PMV Pharma; Summit Therapeutics
Speakers' Bureau - PMV Pharma
Research Funding - A2A Pharmaceuticals (Inst); Aileron Therapeutics (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bolt Biotherapeutics (Inst); Compugen (Inst); Dragonfly Therapeutics (Inst); Fate Therapeutics (Inst); Genentech (Inst); Immunocore (Inst); Immunomedics/Gilead (Inst); Mereo BioPharma 5 (Inst); Mersana (Inst); ModeX Therapeutics (Inst); Pfizer (Inst); PMV Pharma (Inst); Poseida (Inst); Rain Therapeutics (Inst); Sanofi (Inst); Sotio (Inst); Triumvira Immunologics, Inc (Inst); Volastra Therapeutics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Rain Oncology; Triumvira Immunologics, Inc
 
Hyung-Don Kim
Honoraria - AstraZeneca/MedImmune; Boostimmune; Boryung Pharmaceuticals; Bristol Myers Squibb; Daiichi Sankyo; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Mustbio
Research Funding - Roche/Genentech/Foundation Medicine
 
Mariano Ponz-Sarvise
Consulting or Advisory Role - Ability Pharma; AstraZeneca Spain; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Novocure (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Incyte; Oncosil
 
Ye Guo
Honoraria - BeiGene; Merck Serono; MSD; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD